CUTISS closes CHF 56M Series C round and signs agreement with leading EU burn center

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

CUTISS-denovoSkin

More Like This

PR Newswire associated0

Cure51 raises a €15 million seed round to harness the natural power of cancer survivors and contribute to cure this life threatening disease

Dan Coaten (right) presents Dr. Sandra Moritz (center) with the Kerecis Center of Excellence certification. (Photo: Business Wire)

Kerecis Announces First European Center of Excellence for Medical Fish-Skin Technology

T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured

Wyss Geneva Spin-Off Clee Medical Secures Seed Financing to Bring Real-Time Vision to Brain Surgery

PR Newswire associated0

Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs

Curatis: Significantly Increased Sales in Core Business and Projects in Development Pipeline on Track

PR Newswire associated0

Xsensio SA Raises $7M Oversubscribed Series A, Accelerates Clinical Deployment of Continuous Biosensing

PR Newswire associated0

"Innovation Drive Development, Join Hands to Shape the Future" Singclean Celebrating 22 Years of Excellence at MEDICA 2024